• Summary
  • Table Of Content
  • Segmentation
  • Request sample

China Scar Treatment Market Synopsis:

China Scar Treatment Market Size Was Valued at USD 249.2 Million in 2023, and is Projected to Reach USD 760.62 Million by 2032, Growing at a CAGR of 13.2 % From 2024-2032.

The China Scar Treatment market includes products and treatment procedures focused on prevention or elimination of excessive scar formation as a result of surgery, injuries, burn, and acne as well other skin diseases. This market encompasses the topical solutions like creams and gels, non-invvasive treatment like laser, and invasive treatments specific to different kinds of scars including keloids, hypertrophic, and atrophic scars. Several factors make scar treatment popular in China still, this includes a shift in paradigm from health View State, awareness about aesthetic wellness, and skin health in recent years.

The China Scar Treatment Market has continuously experienced growth, due to increased incidences of skin problems, enhanced awareness of aesthetics, and available Scar Treatment procedures. As the Standards of the Chinese middle class rise and their disposable income increases, they are looking for better scar treatments to enhance their aesthetics and skin. The market is also boosted by ongoing improvements in treatment technologies: preferential methods such as laser therapy and radiofrequency microneedles remove scars and help rejuvenate the skin with minimally invasive treatment. More so, with an emergent acceptance of cosmetic surgeries and procedures in China and among the youth especially, there has been a high demand for treatments for scars left behind by the surgeries hence helping the market to grow.

However, the available solutions for effective scar treatment may be quite expensive; for instance, laser therapy is quite expensive. Moreover, it is important to note that skilled dermatologists and certified clinics are still scarce and restrict the market reach, especially during its early stages in less developed regions. However, an increase in the number of dermatology clinics and wellness centers coupled with the increase in the e-commerce market through which a greater number of products of scar treatments can be sold, shall offer a good sign for the growth of the market. As people become more informed regarding scar treatment the China Scar Treatment Market is expected to boom over the forecast period mainly due to the psychological effects of better-looking skin.

China Scar Treatment Market - Comprehensive Study Report & Recent Trends (2024-2032)

China Scar Treatment Market Trend Analysis:

Growing Demand for Minimally Invasive Laser Therapies

  • One of the surge trends in the China Scar Treatment Market is the growing demand for minimally invasive laser therapies. Fractional CO2 laser and pulsed-dye lasers are preferred for the treatments of the of the scars because these procedures Wen outcomes with less down time and maximum accuracy. These therapies work on the layers of the skin helping to encourage collagen production that aids in scar tissue relaxation and overall skin coarseness. Laser treatments are progressively getting safer, efficient, and possibly within the reach of a greater number of people due to great developments in laser technology. Another advantage that contributes to the use of laser therapies include brief treatment durations and low side effects from the treatment thus making laser therapies a suitable treatment for scar patients. As the laser treatment progresses, the improved laser equipment is gradually introduced, more clinics’ introduction of advanced laser equipment will promote the development of this scar treatment market in China.

Expanding Medical Tourism in China

  • The general rise in the medical tourism industry in China could be identified as a good opportunity for scar treatment market. The Chinese healthcare infrastructure attracts more and more foreigners with superior specialist equipment, specialized dermatology and plastic surgery departments, and lower cross-border costs for plastic surgery. Ongoing government campaigning for medical tourism coupled with friendly policies on the part of China have placed the nation as a medical tourist destination providing affordable quality aesthetic procedures. This trend is not only good for the local economy since such individuals are equally demanding for better scar treatment procedures such as lasers and less invasive procedures since they are also interested in other skincare treatments. Thus, the increasing development of medical tourism has positive implications for Chinese scar treatment industry and greater demand from both domestic and overseas patients is expected.

China Scar Treatment Market Segment Analysis:

China Scar Treatment Market is Segmented on the basis of Treatment Type, Application, End User, and Region

By Treatment Type, Laser segment is expected to dominate the market during the forecast period

  • The laser segment is expected to have a higher market share for the China Scar Treatment Market during the forecast period because of the benefits offered by laser treatments for less visibility of scars and enhancements of skin feel. Laser therapies are particularly more popular because they can closely affect only the scarred area of the skin, minimizing the topical side effects and the recovery period. Advancements in the techniques of the laser involve fractional CO2 lasers alongside superior pulsed-dye lasers, and the improved outcome of the treatment makes the therapies acceptable to patients. The growing awareness of the new generation of laser treatments in the dermatology and aesthetic clinics in China and the increasing number of patients with awareness of advanced scar treatments also contribute to the growth of the laser segment. Furthermore, with clinics and wellness centres participating in advanced laser equipment segment also likely to hold a large share of this market.

By Application, Keloid Scars segment expected to held the largest share

  • Out of the two types of the scar treatments, the keloid scars segment is expected to contribute the largest market share in the China Scar Treatment Market because of the high incidence of keloidal scar in specific population and owing to its conspicuousness and functional implications associated with keloid scars. Keloids or rifle butted scars commonly occur in genetically disposed patients and are clinically thicker and more elevated than the original wound edges and normally requires specific management. Treatment approaches to avoid or treat keloid may include laser surgery, cortisone injections, surgical removal of the keloid with or without the use of lasers or injections to prevent recurrence. Since keloids are recurrent formations, patients continually attempt to eliminate them or find the most effective and long-lasting treatment; therefore, there is demand in this segment. Since the healthcare providers of China use an amalgamation of treatments to manage keloids, this segment is expected to remain an important segment in the market.

Active Key Players in the China Scar Treatment Market:

  • Alliance Pharma (UK)
  • Bausch Health Companies Inc. (Canada)
  • Beijing Toplaser Technology Co., Ltd. (China)
  • Biodermis (USA)
  • Cynosure, Inc. (USA)
  • Enaltus LLC (USA)
  • Ferndale Pharmaceuticals Ltd. (UK)
  • Hologic, Inc. (USA)
  • Lumenis Ltd. (Israel)
  • Merz Pharmaceuticals (Germany)
  • Scarguard Labs, LLC (USA)
  • Shanghai Fosun Pharmaceutical Group Co., Ltd. (China)
  • Smith & Nephew plc (UK)
  • Sonoma Pharmaceuticals, Inc. (USA)
  • Stratpharma AG (Switzerland)
  • Other Active Players

China Scar Treatment Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 249.2 Million

Forecast Period 2024-32 CAGR:

13.2 %

Market Size in 2032:

USD 760.62 Million

Segments Covered:

By Treatment Type

  • Surgical
  • Laser
  • Topical
  • Injectable

By Application

  • Keloid Scars
  • Contracture
  • Hypertrophic
  • Acne
  • Others

By End User

  • Hospitals
  • Dermatology clinics

Key Market Drivers:

  • Growing Demand for Aesthetic Wellness and Cosmetic Treatments

Key Market Restraints:

  • High Cost of Advanced Scar Treatment Procedures

Key Opportunities:

  • Increasing Medical Tourism and Rising Disposable Incomes

Companies Covered in the report:

  • Alliance Pharma, Bausch Health Companies Inc., Cynosure, Inc., Hologic, Inc., Shanghai Fosun Pharmaceutical Group Co., Ltd. and Other Active Players.

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: China Scar Treatment Market by Treatment Type
 4.1 China Scar Treatment Market Snapshot and Growth Engine
 4.2 China Scar Treatment Market Overview
 4.3 Surgical
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Surgical: Geographic Segmentation Analysis
 4.4 Laser
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Laser: Geographic Segmentation Analysis
 4.5 Topical
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Topical: Geographic Segmentation Analysis
 4.6 Injectable
  4.6.1 Introduction and Market Overview
  4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.6.3 Key Market Trends, Growth Factors and Opportunities
  4.6.4 Injectable : Geographic Segmentation Analysis

Chapter 5: China Scar Treatment Market by Application
 5.1 China Scar Treatment Market Snapshot and Growth Engine
 5.2 China Scar Treatment Market Overview
 5.3 Keloid Scars
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Keloid Scars: Geographic Segmentation Analysis
 5.4 Contracture
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Contracture: Geographic Segmentation Analysis
 5.5 Hypertrophic
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Hypertrophic: Geographic Segmentation Analysis
 5.6 Acne
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Acne: Geographic Segmentation Analysis
 5.7 Others
  5.7.1 Introduction and Market Overview
  5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.7.3 Key Market Trends, Growth Factors and Opportunities
  5.7.4 Others : Geographic Segmentation Analysis

Chapter 6: China Scar Treatment Market by End User
 6.1 China Scar Treatment Market Snapshot and Growth Engine
 6.2 China Scar Treatment Market Overview
 6.3 Hospitals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals: Geographic Segmentation Analysis
 6.4 Dermatology Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Dermatology Clinics: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 China Scar Treatment Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 ALLIANCE PHARMA (UK)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 BAUSCH HEALTH COMPANIES INC. (CANADA)
 7.4 BEIJING TOPLASER TECHNOLOGY CO. LTD. (CHINA)
 7.5 BIODERMIS (USA)
 7.6 CYNOSURE INC. (USA)
 7.7 ENALTUS LLC (USA)
 7.8 FERNDALE PHARMACEUTICALS LTD. (UK)
 7.9 HOLOGIC INC. (USA)
 7.10 LUMENIS LTD. (ISRAEL)
 7.11 MERZ PHARMACEUTICALS (GERMANY)
 7.12 SCARGUARD LABS LLC (USA)
 7.13 SHANGHAI FOSUN PHARMACEUTICAL GROUP CO. LTD. (CHINA)
 7.14 SMITH & NEPHEW PLC (UK)
 7.15 SONOMA PHARMACEUTICALS INC. (USA)
 7.16 STRATPHARMA AG (SWITZERLAND)
 7.17 OTHER ACTIVE PLAYERS

Chapter 8: Global China Scar Treatment Market By Region
 8.1 Overview
8.2. North America China Scar Treatment Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Treatment Type
  8.2.4.1 Surgical
  8.2.4.2 Laser
  8.2.4.3 Topical
  8.2.4.4 Injectable
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Keloid Scars
  8.2.5.2 Contracture
  8.2.5.3 Hypertrophic
  8.2.5.4 Acne
  8.2.5.5 Others
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Hospitals
  8.2.6.2 Dermatology Clinics
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
8.3. Eastern Europe China Scar Treatment Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Treatment Type
  8.3.4.1 Surgical
  8.3.4.2 Laser
  8.3.4.3 Topical
  8.3.4.4 Injectable
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Keloid Scars
  8.3.5.2 Contracture
  8.3.5.3 Hypertrophic
  8.3.5.4 Acne
  8.3.5.5 Others
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Hospitals
  8.3.6.2 Dermatology Clinics
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
8.4. Western Europe China Scar Treatment Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Treatment Type
  8.4.4.1 Surgical
  8.4.4.2 Laser
  8.4.4.3 Topical
  8.4.4.4 Injectable
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Keloid Scars
  8.4.5.2 Contracture
  8.4.5.3 Hypertrophic
  8.4.5.4 Acne
  8.4.5.5 Others
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Hospitals
  8.4.6.2 Dermatology Clinics
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
8.5. Asia Pacific China Scar Treatment Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Treatment Type
  8.5.4.1 Surgical
  8.5.4.2 Laser
  8.5.4.3 Topical
  8.5.4.4 Injectable
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Keloid Scars
  8.5.5.2 Contracture
  8.5.5.3 Hypertrophic
  8.5.5.4 Acne
  8.5.5.5 Others
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Hospitals
  8.5.6.2 Dermatology Clinics
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
8.6. Middle East & Africa China Scar Treatment Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Treatment Type
  8.6.4.1 Surgical
  8.6.4.2 Laser
  8.6.4.3 Topical
  8.6.4.4 Injectable
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Keloid Scars
  8.6.5.2 Contracture
  8.6.5.3 Hypertrophic
  8.6.5.4 Acne
  8.6.5.5 Others
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Hospitals
  8.6.6.2 Dermatology Clinics
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
8.7. South America China Scar Treatment Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Treatment Type
  8.7.4.1 Surgical
  8.7.4.2 Laser
  8.7.4.3 Topical
  8.7.4.4 Injectable
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Keloid Scars
  8.7.5.2 Contracture
  8.7.5.3 Hypertrophic
  8.7.5.4 Acne
  8.7.5.5 Others
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Hospitals
  8.7.6.2 Dermatology Clinics
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
 

China Scar Treatment Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 249.2 Million

Forecast Period 2024-32 CAGR:

13.2 %

Market Size in 2032:

USD 760.62 Million

Segments Covered:

By Treatment Type

  • Surgical
  • Laser
  • Topical
  • Injectable

By Application

  • Keloid Scars
  • Contracture
  • Hypertrophic
  • Acne
  • Others

By End User

  • Hospitals
  • Dermatology clinics

Key Market Drivers:

  • Growing Demand for Aesthetic Wellness and Cosmetic Treatments

Key Market Restraints:

  • High Cost of Advanced Scar Treatment Procedures

Key Opportunities:

  • Increasing Medical Tourism and Rising Disposable Incomes

Companies Covered in the report:

  • Alliance Pharma, Bausch Health Companies Inc., Cynosure, Inc., Hologic, Inc., Shanghai Fosun Pharmaceutical Group Co., Ltd. and Other Active Players.
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the China Scar Treatment Market research report?

The forecast period in the China Scar Treatment Market research report is 2024-2032.

Who are the key players in the China Scar Treatment Market?

Alliance Pharma (UK), Bausch Health Companies Inc. (Canada), Beijing Toplaser Technology Co., Ltd. (China), Biodermis (USA), Cynosure, Inc. (USA), Enaltus LLC (USA), Ferndale Pharmaceuticals Ltd. (UK), Hologic, Inc. (USA), Lumenis Ltd. (Israel), Merz Pharmaceuticals (Germany), Scarguard Labs, LLC (USA), Shanghai Fosun Pharmaceutical Group Co., Ltd. (China), Smith & Nephew plc (UK), Sonoma Pharmaceuticals, Inc. (USA), Stratpharma AG (Switzerland), and Other Active Players.

What are the segments of the China Scar Treatment Market?

The China Scar Treatment Market is segmented into Treatment Type, Application, End User, and region. By Type, the market is categorized into Surgical, Laser, Topical, and Injectable. By Application, the market is categorized into Keloid Scars, Contracture, Hypertrophic, acne, and Others. By End User, the market is categorized into Hospitals and dermatology clinics.

What is the China Scar Treatment Market?

The China Scar Treatment market includes products and treatment procedures focused on the prevention or elimination of excessive scar formation as a result of surgery, injuries, burns, and acne as well as other skin diseases. This market encompasses topical solutions like creams and gels, non-invasive treatment like a laser, and invasive treatments specific to different kinds of scars including keloids, hypertrophic, and atrophic scars. Several factors make scar treatment popular in China still, this includes a shift in paradigm from health View State, awareness about aesthetic wellness, and skin health in recent years

How big is the China Scar Treatment Market?

China Scar Treatment Market Size Was Valued at USD 249.2 Million in 2023, and is Projected to Reach USD 760.62 Million by 2032, Growing at a CAGR of 13.2 % From 2024-2032.